|
|
 |
|
 |
|
|
|
|
Title:
|
A Phase II Study Evaluating the Role of Sentinel Lymph Node Surgery and Axillary Lymph Node Dissection Following Preoperative Chemotherapy in Women with Node Positive Breast Cancer (T1-4, N1-2, M0) at Initial Diagnosis - IRB #09-071B
|
|
Treatments:
|
Surgery
|
|
Disease Site:
|
Breast
|
|
Disease SubSite:
|
Node positive
|
|
Drug Provided:
|
-- none --
|
|
Comments:
|
|
|
Eligibility:
|
This is a multicenter study. Patients receive neoadjuvant chemotherapy at the discretion of the treating physician. Patients undergo examination for breast and axilla lymph adenopathy and then undergo ultrasound of the axillary nodes at baseline and after completion of neoadjuvant chemotherapy. Within 6 weeks of completing neoadjuvant chemotherapy, patients undergo a mastectomy or lumpectomy including sentinel lymph node and axillary lymph node dissection. After completion of study treatment, patients are followed every 6 months for 2 years, yearly for 2 years, then every other year for 6 years.
|
|
Participating Sites:
|
Adventist Medical Center, Northwest Cancer Specialists, Providence Milwaukie Hospital, Providence Portland Medical Center, Providence St. Vincent Medical Center, Southwest Washington Medical Center
|
|
|
|
|
 |
|
 |
|
|
|